Autor/in Bacher, Ulrike 1 Haferlach, C Haferlach, T 1 Hertenstein, B Kern, W Schnittger, S 1 alle zeigenListe einklappen
A new case with rare e6a2 BCR-ABL fusion transcript developing two new resistance mutations during imatinib mesylate, which were replaced by T315I after subsequent dasatinib treatment. Schnittger, S Bacher, Ulrike Kern, W Haferlach, T Hertenstein, B Haferlach, C 2008 - Forschungsinformationssystem des UKE
